Neutral endopeptidase : variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux

• Published in: Cancer research (Chicago, Ill.) Ill.), 1996-02, Vol.56 (4), p.831-839
• Main Authors: COHEN, A. J, BUNN, P. A, FRANKLIN, W, MAGILL-SOLC, C, HARTMANN, C, HELFRICH, B, GILMAN, L, FOLKVORD, J, HELM, K, MILLER, Y. E
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - metabolism; Adenocarcinoma - pathology; Adenocarcinoma - surgery; Adult; Base Sequence; Biological and medical sciences; Blotting, Western; Bradykinin - pharmacology; Calcium - metabolism; Carcinoma, Non-Small-Cell Lung - metabolism; Carcinoma, Non-Small-Cell Lung - pathology; Carcinoma, Non-Small-Cell Lung - surgery; Carcinoma, Small Cell - metabolism; Carcinoma, Small Cell - pathology; Carcinoma, Small Cell - surgery; Carcinoma, Squamous Cell - metabolism; Carcinoma, Squamous Cell - pathology; Carcinoma, Squamous Cell - surgery; Cell Line; DNA Primers; Enzyme Inhibitors - pharmacology; Gastrin-Releasing Peptide; Gene Expression; Glycopeptides - pharmacology; Humans; Immunohistochemistry; Lung - metabolism; Lung - pathology; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Lung Neoplasms - surgery; Medical sciences; Mesothelioma - metabolism; Mesothelioma - pathology; Mesothelioma - surgery; Molecular Sequence Data; Neoplasm Metastasis; Neprilysin - antagonists & inhibitors; Neprilysin - biosynthesis; Neprilysin - metabolism; Peptides - pharmacology; Pneumology; Polymerase Chain Reaction; Pulmonary Alveoli - metabolism; Recombinant Proteins - pharmacology; RNA, Messenger - analysis; RNA, Messenger - biosynthesis; Signal Transduction; Tumor Cells, Cultured; Tumors of the respiratory system and mediastinum
• ISSN: 0008-5472; 1538-7445

Neutral endopeptidase (NEP; CALLA, CD10, EC 3.4.24.11) is a cell surface endopeptidase that hydrolyses bioactive peptides, including the bombesin-like peptides, as well as other neuropeptides. Bombesin-like peptides and other neuropeptides are autocrine growth factors for both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Low expression of NEP has been reported in SCLC and NSCLC cell lines. NEP inhibition has been shown to increase proliferation in one cell line. To date, NEP expression has not been quantitatively evaluated in normal adult lung, SCLC or NSCLC tumors, paired uninvolved lung from the same patient, or in other pulmonary neoplasms such as mesotheliomas and carcinoids. We examined the expression of NEP in these tissues and human cell lines using immunohistochemistry, flow cytometry, enzyme activity, ELISA, Western blot, and reverse transcription (RT)-PCR. Uninvolved lung tissue from different individuals displayed considerable variation in NEP activity and protein. By immunohistochemistry, NEP expression was detectable in alveolar and airway epithelium, fibroblasts of normal lung, and in mesotheliomas, whereas it was undetectable in most SCLC, adenocarcinoma, squamous cell carcinoma, and carcinoid tumors of the lung. NEP activity and protein levels were lower in all SCLC and adenocarcinoma tumors when compared to adjacent uninvolved lung, often at levels consistent with expression derived from contaminating stroma. NEP expression and activity were reduced or undetectable in most SCLC and lung adenocarcinoma cell lines. NEP mRNA by RT-PCR was not expressed or was in low abundance in the majority of lung cancer cell lines. The majority of lung tumors did not express NEP by RT-PCR as compared with normal adjacent lung. In addition, recombinant NEP abolished, whereas an NEP inhibitor potentiated, the calcium flux generated by neuropeptides in some lung cancer cell lines, demonstrating potential physiological significance for low NEP expression. NEP, therefore, is a signal transduction and possibly a growth modulator for both SCLC and NSCLC, emphasizing the role of neuropeptides in the pathogenesis of the major histological forms of lung cancer.